Pancreatic Cancer Research

ResearcherUniversity of North Texas Health Science CenterNo recent work listed

Amalendu Prakash Ranjan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3641-7751; OpenAlex author ID A5007921828. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 2

  1. Novel Use of Hypoxia-Inducible Polymerizable Protein to Augment Chemotherapy for Pancreatic Cancer. Last author DOI 10.3390/pharmaceutics14010128↗
  2. Investigational agents to enhance the efficacy of chemotherapy or radiation in pancreatic cancer. Co-author DOI 10.1016/j.critrevonc.2018.03.016↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Andrew Gdowski · 1 shared paper, 2022 · strength 0.16
  2. Umesh T. Sankpal · 1 shared paper, 2018 · strength 0.09
  3. Riyaz M. Basha · 1 shared paper, 2018 · strength 0.09
  4. Myrna Hurtado · 1 shared paper, 2018 · strength 0.09
  5. Ganji Purnachandra Nagaraju · 1 shared paper, 2018 · strength 0.09
  6. Bassel F. El‐Rayes · 1 shared paper, 2018 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.